The disease of corruption: Views on how to fight corruption to advance 21st century global health goals

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Mackey, Tim K ^a,b,c,d   Kohler, Jillian Clare ^d   Savedoff, William D ^e   Vogl, Frank ^f,g   Lewis, Maureen ^h,i   Sale, James ^f   Michaud, Joshua ^j,k   Vian, Taryn ^l  

^a University of California at San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Global Health Policy Institute   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e CENTER FOR GLOBAL DEVELOPMENT   (United States)

^f Transparency International Bangladesh   (United Kingdom)

^g The Partnership for Transparency Fund   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ Aceso Global   (United States)

^j HENRY J KAISER FAMILY FOUNDATION   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Anti corruption; Corruption; Global health; Global health governance; Good governance; International development; Sustainable Development Goals

Indexed keywords

ABSENTEEISM; ARTICLE; CORRUPTION; COST CONTROL; EMPOWERMENT; FUNDING; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EQUITY; HEALTH PROGRAM; HUMAN; LEADERSHIP; POVERTY; PUBLIC HEALTH PROBLEM; PUBLIC-PRIVATE PARTNERSHIP; PURCHASING; SOCIAL PROBLEM;

EID: 84992166131     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0696-1     Document Type: Article

References (92)

1. People and Development: address to the Board of Governors, Washington, DC, October 1, 1996 (English). http://documents.worldbank.org/curated/en/243871468141893629/People-and-development-address-to-the-Board-of-Governors-Washington-DC-October-1-1996. Accessed 5 Aug 2016.
2. Mackey TK, Liang BA. Combating healthcare corruption and fraud with improved global health governance. BMC Int Health Hum Rights. 2012;12:23.
3. Transparency International. Global Corruption Report 2006: Corruption and Health. London and Ann Arbor: Pluto Press and Transparency International; 2006.
4. UNDP. Fighting Corruption in the Health Sector: Methods, Tools and Good Practices. 2011. http://www.undp.org/content/undp/en/home/librarypage/democratic-governance/anti-corruption/fighting_corruptioninthehealthsector.html. Accessed 7 May 2012.
5. Savedoff W, Glassman A, Madan J. Global Health, Aid and Corruption: Can We Escape the Scandal Cycle? CGD Policy Paper 086. Washington DC: Center for Global Development; 2016. http://www.cgdev.org/publication/global-health-aid-and-corruption-can-we-escape-scandal-cycle. Accessed 14 Jun 2016.
6. DiJulio B, Norton M, Brodie M. Americans' views on the U.S. role in global health. 2016. Kaiser Family Foundation. http://kff.org/global-health-policy/poll-finding/americans-views-on-the-u-s-role-in-global-health/. Accessed 6 Jun 2016.
7. Transparency International. Global Corruption Barometer 2013: Report. https://www.transparency.org/gcb2013/report/. Accessed 6 Jun 2016.
8. Health expenditure, total (% of GDP). 2016. http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS. Accessed 5 Aug 2016.
9. Vian T. Review of corruption in the health sector: theory, methods and interventions. Health Policy Plan. 2008;23:83-94.
10. Usher AD. Global Fund plays hard ball on corruption. Lancet. 2016;387:213-4.
11. Godlee F. Medical corruption in the UK. BMJ. 2015;350:h506-6.
12. Liang BA, Mackey T. Confronting conflict: addressing institutional conflicts of interest in academic medical centers. Am J Law Med. 2010;36:136-87.
13. Frenk J, Moon S. Governance challenges in global health. N Engl J Med. 2013;368:936-42.
14. Institute for Health Metrics and Evaluation. Financing Global Health 2015: Development assistance steady on the path to new global goals. 2016. http://www.healthdata.org/policy-report/financing-global-health-2015-development-assistance-steady-path-new-global-goals. Accessed 5 Aug 2016.
15. Levine R, The What Works Working Group. Millions saved: proven successes in global health. Washington, DC: Center for Global Development; 2004.
16. Glassman A, Temin M, The Million Saved Team and Advisory Group. Millions saved: new cases of proven success in global health. Washington, DC: Center for Global Development; 2016.
17. Norwegian Agency for Development Cooperation. Anti-corruption approaches: a literature review. Evaluation studies 2/2008. Oslo: Norad; 2008.
18. Persson A, Rothstein B, Teorell J. Why anticorruption reforms fail-systemic corruption as a collective action problem. Governance. 2013;26(3):449-71.
19. Vian T, Savedoff W, Mathisen H, editors. Anticorruption in the Health Sector: Strategies for Transparency and Accountability. Sterling: Kumarian Press; 2010.
20. Casartelli G, Wolfstetter E. World Bank Policy on the Selection and Employment of Consultants: Study of its Effectiveness. Washington, DC: World Bank; 2007.
21. U4 Anti-Corruption Resource Center. Ebola and Corruption: Overcoming Critical Governance Challenges in a Crisis Situation. http://www.u4.no/publications/ebola-and-corruption-overcoming-critical-governance-challenges-in-a-crisis-situation/. Accessed 5 Aug 2016.
22. World Bank. World Development Report: The State in a Changing World. Washington, DC: World Bank; 2007.
23. Bardhan P. Corruption and development: a review of issues. J Econ Lit. 1997;35(3):1320-46.
24. Lewis M, Pettersson G. Governance in Health Care Delivery: Raising Performance. Policy Research Working Paper No. 5074. Washington, DC: World Bank; 2009.
25. Oxford English Dictionary. Oxford: Oxford University Press; 2014.
26. Transparency International. People and Corruption: The Middle East and North Africa Survey 2016. http://www.transparency.org/whatwedo/publication/people_and_corruption_mena_survey_2016. Accessed 5 Aug 2016.
27. Transparency International. People and Corruption: Africa Survey 2015 - Global Corruption Barometer. http://www.transparency.org/whatwedo/publication/people_and_corruption_africa_survey_2015. Accessed 5 Aug 2016.
28. Citizen Action Platform. http://www.citizenactionplatform.org/. Accessed 5 Aug 2016.
29. Partnership for Transparency Fund. Citizen Action Platform. http://ptfund.org/project/cap/. Accessed 5 Aug 2016.
30. Partnership for Transparency Fund. Healthcare Delivery. http://ptfund.org/health/. Accessed 5 Aug 2016.
31. Africa Progress Panel. Africa Progress Report 2013. http://www.africaprogresspanel.org/publications/policy-papers/africa-progress-report-2013/. Accessed 5 Aug 2016.
32. World Health Organization. Spending on Health: A Global Overview. 2012. http://www.who.int/mediacentre/factsheets/fs319/en/. Accessed 5 Aug 2016.
33. Open Contracting Partnership. Why Open Contracting. http://www.open-contracting.org/why-open-contracting/. Accessed 5 Aug 2016.
34. Open Contracting Partnership. Open Contracting Data Standard: Documentation. http://standard.open-contracting.org/latest/en/. Accessed 5 Aug 2016.
35. GOV.UK. Anti-Corruption Summit Communique. 2016. https://www.gov.uk/government/publications/anti-corruption-summit-communique. Accessed 5 Aug 2016.
36. GOV.UK. Scaling Up the UN response to Corruption. UN Commitments. 2016. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/522743/United_Nations.pdf. Accessed 5 Aug 2016.
37. United Nations Development Programme. UNDP Medicine Procurement Support Services for the Government and People of Ukraine. 2015. http://www.ua.undp.org/content/ukraine/en/home/presscenter/speeches/2015/12/10/undp-s-medicine-procurement-support-services-for-the-government-and-people-of-ukraine.html. Accessed 5 Aug 2016.
38. The New Statesman. Is Ukraine finally getting to grips with its corruption problem? 2015. http://www.newstatesman.com/world/europe/2015/11/ukraine-finally-getting-grips-its-corruption-problem. Accessed 5 Aug 2016.
39. United Nations Development Programme. UNDP to Procure Life-Saving Medicines for Ukraine. 2016. http://www.ua.undp.org/content/ukraine/en/home/presscenter/articles/2016/02/26/undp-to-procure-life-saving-medicines-for-ukraine.html. Accessed 5 Aug 2016.
40. Centre for Economic Strategy. Top Twelve Biggest Achievements of the Ukrainian Reforms. 2016. http://ces.org.ua/en/top-twelve-biggest-achievements-of-the-ukrainian-reforms/. Accessed 5 Aug 2016.
41. ProZorro. http://bi.prozorro.org/. Accessed 5 Aug 2016.
42. Wambo.org. About Wambo.org. http://www.wambo.org/about-wambo-org. Accessed 5 Aug 2016.
43. The Global Fund. Wambo.org to Bring Better Access, Prices, Transparency to Global Health. 2016. http://www.theglobalfund.org/en/news/2016-05-25_Wambo_org_to_Bring_Better_Access_Prices_Transparency_to_Global_Health/. Accessed 5 Aug 2016.
44. UNAIDS. On the Fast-Track to End AIDS. UNAIDS 2016-2021 Global Strategy. 205. http://www.unaids.org/sites/default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf. Accessed 30 May 2016.
45. World Health Organization. World Medicines Situation. Chapter 7: Access to Essential Medicines. WHO: Geneva; 2004.
46. Kohler JC, Mackey TK, Ovtcharenko N. Why the MDGs need good governance in pharmaceutical systems to promote global health. BMC Public Health. 2014;14:63.
47. Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M. How to achieve international action on falsified and substandard medicines: a consensus statement. BMJ. 2012;345:e738.
48. Kohler JC, Ovtcharenko N. Good governance for medicines initiatives: Exploring lessons learned. Bergen: Chr. Michelsen Institute; 2013.
49. The New York Times. Stemming the Tide of Fake Medicines. May 18, 2015. http://www.nytimes.com/2015/05/18/opinion/stemming-the-tide-of-fake-medicines.html?_r=0. Accessed 5 Aug 2016.
50. Transparency International. Corruption in the Pharmaceutical Sector: Diagnosing the Challenges. 2016. http://www.transparency.org.uk/publications/corruption-in-the-pharmaceutical-sector/. Accessed 5 Aug 2016.
51. National Academy of Medicine. The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Crises. Washington, DC: National Academies Press; 2016.
52. Michaud J, Kates J, Oum S. Corruption and Global Health: Summary of a Policy Roundtable. Oakland: Kaiser Family Foundation; 2015.
53. Savedoff W, Hussmann K. Why are health systems prone to corruption? Global Corruption Report 2006. London and Ann Arbor: Pluto Press and Transparency International; 2006. p. 4-13.
54. Lewis M. Governance and corruption in public health care systems. Center for Global Development Working Paper 78. 2006. http://www.cgdev.org/publication/governance-and-corruption-public-health-care-systems-working-paper-78. Accessed 5 Aug 2016.
55. Witvliet MI, Kunst AE, Arah OA, Stronks K. Sick regimes and sick people: a multilevel investigation of the population health consequences of perceived national corruption. Trop Med Int Health. 2013;18(10):1240-7.
56. Karunamoorthi K. The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence. Malar J. 2014;13:209.
57. Bosley S. World Health Organization Admits Botching Response to Ebola Outbreak. Oct 17, 2014. https://www.theguardian.com/world/2014/oct/17/world-health-organisation-botched-ebola-outbreak. Accessed 5 Aug 2016.
58. Sack K, Fink S, Belluck P, Nossiter A. How Ebola Roared Back. New York Times Dec 29, 2014. http://www.nytimes.com/2014/12/30/health/how-ebola-roared-back.html?_r=0. Accessed 5 Aug 2016.
59. Cheng M, Satter R, Larson K. Mistakes by WHO Hindered Ebola Response in Sierra Leone: Investigation. Globe and Mail. 21 Sep 2015. http://www.theglobeandmail.com/news/world/mistakes-by-who-hindered-ebola-response-in-sierra-leone-investigation/article26451355/. Accessed 5 Aug 2016.
60. Garrett L. Secret Vote on WHO Bodes Ill for Future of Global Health. Humanosphere. 23 May 2016. http://www.humanosphere.org/world-politics/2016/05/secret-vote-on-who-bodes-ill-for-future-of-global-health/. Accessed 5 Aug 2016.
61. Pieterse P, Lodge T. When free healthcare is not free. Corruption and mistrust in Sierra Leone's primary healthcare system immediately prior to the Ebola outbreak. Int Health. 2015;5:400-4.
62. Cohn S, Kutalek R. Historical Parallels, Ebola Virus Disease and Cholera: Understanding Community Distrust and Social Violence with Epidemics. PLoS Current Outbreaks. 2016; Edition 1. doi: 10.1371/currents.outbreaks.aa1f2b60e8d43939b43fbd93e1a63a94.
63. Eckholm E. The SARS Epidemic: China Admits Underreporting Its SARS Cases. New York Times. 21 April 2003. http://www.nytimes.com/2003/04/21/world/the-sars-epidemic-epidemic-china-admits-underreporting-its-sars-cases.html?pagewanted=all. Accessed 5 Aug 2016.
64. Sang-Hun C. Experts Fault South Korean Response to MERS. 13 June 2015. New York Times. http://www.nytimes.com/2015/06/14/world/asia/experts-fault-south-korean-response-to-mers-outbreak.html. Accessed 5 Aug 2016.
65. IRIN News. Lessons to be Learned from the MERS Outbreak. 27 August 2014. http://www.irinnews.org/analysis/2014/08/27/lessons-be-learned-mers-outbreak. Accessed 5 Aug 2016.
66. NPR. Government's Secrecy Contributes To Zika Outbreak In Venezuela, Critics Say. 5 April 2016. http://www.npr.org/2016/04/05/473063718/government-s-secrecy-contributes-to-zeka-outbreak-in-venezuela-critics-say. Accessed 5 Aug 2016.
67. Chunara R, Freifeld CC, Brownstein JS. New technologies for reporting real-time emergent infections. Parasitology. 2012;139(14):1843-51.
68. Santillana M, Nguyen AT, Dredze M, Paul MJ, Nsoesie EO, Brownstein JS. Combining search, social media, and traditional data sources to improve influenza surveillance. PLoS Comp Biol. 2015;11(10):e1004513.
69. Olson SH, Benedum CM, Mekaru SR, Preston ND, Mazet JA, Joly DO, Brownstein JS. Drivers of emerging infectious disease events as a framework for digital detection. Emerg Infect Dis. 2015;21(8):1285-92.
70. Wilson K, Brownstein JS, Fidler DP. Strengthening the International Health Regulations: lessons from the H1N1 pandemic. Health Policy Plan. 2010;25:505-9.
71. New York Post. Mayor During Katrina Gets 10 Years for Corruption. 9 July 2014. http://nypost.com/2014/07/09/mayor-during-katrina-gets-10-years-for-corruption/. Accessed 5 Aug 2016.
72. Nikolova E, Marinov N. Do Public Fund Windfalls Increase Corruption? Evidence from a Natural Disaster. Social Science Research Network. http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2747753. Accessed 5 Aug 2016.
73. Maxwell D, Bailey S, Harvey P, Walker P, Sharbatke-Church C, Savage K. Preventing corruption in humanitarian assistance: perception, gaps, and challenges. Disasters. 2012;36(1):140-60.
74. Sahir JS. Sierra Leone's missing Ebola millions. IRIN News. 30 March 2015. http://www.irinnews.org/analysis/2015/03/30. Accessed 5 Aug 2016.
75. Reuters. Liberia Watchdog says some Ebola Funds Unaccounted For. 9 April 2015. http://www.reuters.com/article/us-health-ebola-liberia-idUSKBN0N025G20150409. Accessed 5 Aug 2016.
76. Trenwith C. Saudi Arabia suspects $266 m worth of 'corruption' related to MERS. 21 January 2015. http://www.arabianbusiness.com/saudi-arabia-suspects-266m-worth-of-corruption-related-mers-579337.html#.V0ih22grJhE. Accessed 5 Aug 2016.
77. Dupuy K, Divjak B. Ebola and Corruption: Overcoming Critical Governance Challenges in a Crisis Situation. U4 Anti-Corruption Centre Brief, March 2014. http://www.cmi.no/publications/file/5522-ebola-and-corruption.pdf. Accessed 5 Aug 2016.
78. United Nations. Transforming our World: The 2030 Agenda for Sustainable Development. A/RES/70/1. New York: United Nations; 2015.
79. United Nations. Goal 3: Ensure Healthy Lives and Promote Well-being for All at All Ages. http://www.un.org/sustainabledevelopment/health/. Accessed 5 Aug 2016.
80. Brinkerhoff DW, Bossert TJ. Health governance: principal-agent linkages and health system strengthening. Health Policy Plan. 2014;29(6):685-93.
81. Report of the Inter-Agency and Expert Group on Sustainable Development Goal Indicators. E/CN.3/2016/2. http://unstats.un.org/unsd/statcom/47th-session/documents/2016-2-IAEG-SDGs-E.pdf. Accessed 5 Aug 2016.
82. Kankeu HT, Ventelou B. Socioeconomic inequalities in informal payments for health care: An assessment of the 'Robin Hood' hypothesis in 33 African countries. Soc Sci Med. 2016;151:173-86.
83. Avelino G, Barberia LG, Biderman C. Governance in managing public health resources in Brazilian municipalities. Health Policy Plan. 2014;29(6):694-702.
84. Miller K, Vian T. Strategies for reducing informal payments. In: Vian T, Savedoff WD, Mathisen H, editors. Anticorruption in the Health Sector: Strategies for Transparency and Accountability. Sterling: Kumarian Press; 2010. p. 55-66.
85. Falkingham J, Akkazieva B, Baschieri A. Trends in out-of-pocket payments for health care in Kyrgyzstan, 2001-2007. Health Policy Plan. 2010;25(5):427-36.
86. Elbahnasawy NG. E-government, internet adoption, and corruption: an empirical investigation. World Dev. 2014;57:114-26.
87. Garuba HA, Kohler JC, Huisman AM. Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers. Glob Health. 2009;5(1):1-13.
88. Bjorkman M, Svensson J. Power to the people: evidence from a randomized field experiment on community-based monitoring in Uganda. Quart J Econ. 2009;124(2):735-69.
89. European Commission - Directorate-General Home Affairs. Study on Corruption in the Healthcare Sector. HOME/2011/ISEC/PR/047-A2. Luxembourg: Publications Office of the European Union; 2013.
90. World Health Organization. WHO/Health Action International Project on Medicine Prices and Availability. http://www.who.int/medicines/areas/access/medicine_prices_and_availability/en/. Accessed 5 Aug 2016.
91. Vian T. Implementing a transparency and accountability policy to reduce corruption: The GAVI Alliance in Cameroon. U4 Brief 9. Bergen: U4 Anticorruption Resource Centre, Chr. Michelsen Institute; 2013.
92. Vian T, Feeley FG, Domente S, Negruta A, Matei A, Habicht J. Barriers to universal health coverage in Republic of Moldova: a policy analysis of formal and informal out-of-pocket payments. BMC Health Serv Res. 2015;15:319.